Evidence for a schedule-dependent deleterious interaction between paclitaxel, vinblastine and cisplatin (PVC) in the treatment of advanced transitional cell carcinoma

A phase II study to evaluate the efficacy and toxicity of the combination of vinblastine, paclitaxel and cisplatin (PVC) in previously untreated patients with advanced transitional cell carcinoma. Chemotherapy naive patients with locally advanced or metastatic transitional cell carcinoma received th...

Descripción completa

Detalles Bibliográficos
Autores principales: Mulatero, C, McClaren, B R, Mason, M, Oliver, R T D, Gallagher, C J
Formato: Texto
Lenguaje:English
Publicado: Nature Publishing Group 2000
Materias:
Regular Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2363438/
https://www.ncbi.nlm.nih.gov/pubmed/11104554
http://dx.doi.org/10.1054/bjoc.2000.1480

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2363438/
https://www.ncbi.nlm.nih.gov/pubmed/11104554
http://dx.doi.org/10.1054/bjoc.2000.1480

Ejemplares similares